1. "2014"
Formats
  1. Journal Article (2603)
  2. Meeting Abstract (1417)
  3. Book Section (235)
  4. Conference Paper (23)
  5. Book Whole (16)
  6. Review (3)
Groups
  1. Department of Medicine (1584)
  2. GSK Faculty (1082)
  3. Surgery (895)
  4. Solid Tumor Oncology Division (840)
  5. Center for Hematologic Malignancies (703)
  6. Sloan Kettering Institute Faculty (672)

More Groups

People
  1. Jedd Wolchok (71)
  2. Sergio Giralt (71)
  3. Ross Levine (69)
  4. Martin Tallman (62)
  5. Michael Berger (59)
  6. Mithat Gonen (55)

More People

Years
  1. 2014 (4297)
Publications
  1. Journal of Clinical Oncology (420)
  2. Blood (228)
  3. International Journal of Radiation Oncology, Biology, Physics (131)
  4. Cancer Research (104)
  5. Modern Pathology (89)
  6. Laboratory Investigation (82)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (446)
  3. Springer (318)
  4. Elsevier Science, Inc. (246)
  5. Nature Publishing Group (242)
  6. American Society of Hematology (230)

More Publishers

Results (4297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Determination of cancer susceptibility in probands with breast and ovarian cancer
    Meeting Abstract

    Schrader, K. A.; Maxwell, K. N.; Vijai, J.; Hart, S.; Thomas, T.; Wubbenhorst, B.; Guidugli, L.; Klein, R.; Corines, M.; Zhang, L.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Blockade of EGFR and HER3 enhances PI3K/Akt antitumor activity in triple negative breast cancer
    Meeting Abstract

    Scaltriti, M.; Tao, J.; Castel, P.; Radosevic-Robin, N.; Elkabets, M.; Auricchio, N.; Juric, D.; Penault-Llorca, F.; Baselga, J.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Microbiome in oral epithelial dysplasia and squamous cell carcinoma
    Meeting Abstract

    Saxena, D.; Pushalkar, S.; Devotta, A.; Li, Y. H.; Singh, B.; Kurago, Z. K.; Kerr, A.; Yan, W. B.; Sacks, P.; Li, X.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Targeted capture next generation sequencing of fresh frozen lobular carcinoma in situ and invasive lobular cancer identifies a common repertoire of mutations
    Meeting Abstract

    Sakr, R. A.; Scarpa, J. V. ; Schizas, M.; Giri, D.; De Brot, M.; Towers, R.; Ng, C. K. Y.; Lim, R.; Andrade, V. P.; Weigelt, B.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Meeting Abstract

    Sadelain, M.; Brentjens, R.; Davila, M.; Riviere, I.; Wang, X. Y.; Bartido, S.; Park, J.; Bouhassira, D.; Curran, K.; Chung, S.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • PNA as novel targeted cancer therapy for BRAF(V600E) mutant melanoma
    Meeting Abstract

    Rothman, J. H.; Surriga, O.; Vasudeva, S. D.; Ambrosini, G.; Ouerfelli, O.; Schwartz, G. K.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • AFM13: An antigen specific immunotherapy for the treatment of CD30+ malignancies: Results of first-in-man study in relapsed/refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Rothe, A.; Reiners, K. S.; Topp, M. S.; Younes, A.; von Tresckow, B.; Hummel, H. D.; Kessler, J.; Ravic, M.; Marschner, J. P.; von Strandmann, E. P.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Acquired resistance to rapamycin and mTOR kinase inhibitors is mediated by non-overlapping mutations in distinct sites in the mTOR protein
    Meeting Abstract

    Rodrik - Outmezguine, V. S.; Yao, Z.; Mukherjee, R.; Cai, L.; Barratt, D.; Ward, R.; Klinowska, T.; Destanchina, E.; Berger, M.; Baselga, J.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Predictive biomarker identification for combined anti-mTOR and anti-IGF-1R treatment in luminal B breast cancer
    Meeting Abstract

    Rivas, M. A.; Ibrahim, Y. H.; Rodriguez, O.; Antón, P.; Cozar, P.; Gomez-Pardo, P.; Aura, C.; Haines, B. B.; Sathyanarayanan, S.; Zhang, T.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with abiraterone acetate (AA)
    Meeting Abstract

    Rathkopf, D. E.; Antonarakis, E. S.; Shore, N. D.; Tutrone, R.; Alumkal, J. J.; Ryan, C. J.; Saleh, M. N.; Hauke, R. J.; Bandekar, R.; Maneval, E. C.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save